Ubs Global Asset Management Americas »

Viking Therapeutics shares owned by Ubs Global Asset Management Americas

Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by Ubs Global Asset Management Americas from 13F filings

Historical chart of Ubs Global Asset Management Americas investment in Viking Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viking Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viking Therapeutics by Ubs Global Asset Management Americas

Quarter filed Position value Share count Share price at filing
2024-03-31 $29M 356k 82.00
2023-12-31 $8.8M 475k 18.61
2023-09-30 $5.3M 479k 11.07
2022-03-31 $334k 111k 3.00
2021-12-31 $511k 111k 4.60
2021-09-30 $698k 111k 6.28
2021-06-30 $774k 129k 5.99
2021-03-31 $634k 100k 6.33
2020-12-31 $420k 72k 5.82
2020-09-30 $420k 72k 5.82
2020-06-30 $520k 72k 7.21
2020-03-31 $406k 87k 4.68
2019-12-31 $702k 88k 8.02
2019-09-30 $559k 81k 6.88
2019-06-30 $545k 66k 8.30
2019-03-31 $470k 47k 9.94
2018-12-31 $205k 27k 7.65